Effective 01 Jan 2017, see footnote
579.082. Marketing of ephedrine or pseudoephedrine — penalty. — 1. A person commits the offense of unlawful marketing of ephedrine or pseudoephedrine if he or she knowingly markets, sells, distributes, advertises, or labels any drug product containing ephedrine, its salts, optical isomers and salts of optical isomers, or pseudoephedrine, its salts, optical isomers and salts of optical isomers, for indication of stimulation, mental alertness, weight loss, appetite control, energy or other indications not approved under the pertinent federal over-the-counter drug Final Monograph or Tentative Final Monograph or approved new drug application.
2. The offense of unlawful marketing of ephedrine or pseudoephedrine is a class E felony.
--------
(L. 1996 H.B. 1301 & 1298, A.L. 2014 S.B. 491)
Transferred 2014; formerly 195.248; Effective 1-01-17